Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Brain Cancer
FDA OKs Berubicin for GBM Treatment
BY KRISTI ROSA
AV-GBM-1 Vaccine Improves Glioblastoma Outcomes
BY KRISTI ROSA
FDA Grants Fast Track Status to Paxalisib for GBM Treatment
BY KRISTI ROSA
FDA Grants Fast Track Status to Enzastaurin to Treat Newly Diagnosed GBM
BY KRISTI ROSA
FDA Accepts BLA for Bevacizumab Biosimilar
BY GINA COLUMBUS
Checkpoint Blockade Plus Vaccines Show Synergy in Early GBM Trials
BY BRIELLE BENYON
New Agents Show Promise in Treating Patients with IDH1-Mutant Low-Grade Glioma
BY GINA COLUMBUS
FDA Approves Bevacizumab Biosimilar for 5 Cancer Types
BY BRIELLE BENYON
Quality of Life Is an Important Endpoint in Cancer Trials
BY GIUSEPPE LOMBARDI, MD, PHD
App for Tracking GBM Symptoms May Fuel Cancer Advancements
BY BRIELLE BENYON
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.